Effect of human atrial natriuretic peptide for prevention of atrial fibrillation after CABG: a randomised controlled trial

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: intra‐and perioperative administration of hANP intra‐and perioperative non‐administration of hANP CONDITION: myocardial infarction, angina PRIMARY OUTCOME: Incidence of postoperative atrial fibrillation SECONDARY OUTCOME: 1) age ; 2) cyclic GMP; 3) renin activity, angiotensin‐II, aldsterone ; 4) CK‐MB, Tp‐I, H‐FABP ; 5) mortality, complication INCLUSION CRITERIA: Patient undergoing isolated CABG patients from whom informed consent was obtained
Epistemonikos ID: 167fe9beedb059f991488e390351023ba54ce65e
First added on: Aug 22, 2024